Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Beximco Pharmaceuticals Limited is set to hold its 48th Annual General Meeting virtually on December 29, 2024, where shareholders will discuss key agenda items, including the adoption of financial statements, a 40% cash dividend, and the election of directors. A significant resolution is proposed for changing the company name to Beximco Pharmaceuticals PLC, reflecting a strategic rebranding move. This AGM comes at a pivotal time for the company, offering shareholders a chance to engage with the company’s future direction.
For further insights into GB:BXP stock, check out TipRanks’ Stock Analysis page.